Electroporation Boosts Cancer Treatment with Antisense Oligonucleotides and Chemotherapy
Author Information
Author(s): Spugnini Enrico P, Biroccio Annamaria, De Mori Roberta, Scarsella Marco, D'Angelo Carmen, Baldi Alfonso, Leonetti Carlo
Primary Institution: Regina Elena Cancer Institute
Hypothesis
Can electroporation enhance the delivery and efficacy of the bcl-2 antisense G3139 and chemotherapy in human melanoma xenografts?
Conclusion
Electroporation significantly improves the delivery of antisense oligodeoxynucleotides to tumor cells, enhancing the effectiveness of melanoma treatment.
Supporting Evidence
- The combination of G3139 and electroporation resulted in over 50% tumor weight inhibition.
- Electroporation led to a significant increase in the uptake of G3139 in tumor cells.
- Treatment with G3139 and electroporation resulted in a marked reduction of bcl-2 protein expression.
Takeaway
Using electric pulses can help deliver cancer-fighting drugs better into tumors, making them work more effectively against melanoma.
Methodology
Melanoma-bearing nude mice were treated with G3139 and/or cisplatin followed by electroporation, with various analyses performed to assess tumor response.
Limitations
The study was conducted in a mouse model, which may not fully replicate human responses.
Participant Demographics
CD-1 male nude mice, 6-8 weeks old, weighing 22-24 g.
Statistical Information
P-Value
0.007
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website